OpenAI’s GPT‑Rosalind aims to outpace DeepMind’s AlphaFold in protein folding, drug discovery, and genomics
What happens when the company behind ChatGPT aims its AI firepower at the molecular machinery of life? According to new reporting, OpenAI has quietly begun early access to GPT‑Rosalind, a life sciences–focused model that’s positioned to challenge Google DeepMind’s AlphaFold in protein structure prediction—and expand far beyond it. If accurate, the claims are attention‑grabbing: more…